BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25764012)

  • 1. Landscape of chromosomal copy number aberrations in gangliogliomas and dysembryoplastic neuroepithelial tumours.
    Prabowo AS; van Thuijl HF; Scheinin I; Sie D; van Essen HF; Iyer AM; Spliet WG; Ferrier CH; van Rijen PC; Veersema TJ; Thom M; Schouten-van Meeteren AY; Reijneveld JC; Ylstra B; Wesseling P; Aronica E
    Neuropathol Appl Neurobiol; 2015 Oct; 41(6):743-55. PubMed ID: 25764012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of multiplex ligation-dependent probe amplification (MLPA) and low pass whole genome sequencing (LP-WGS) to the classification / characterisation of low grade glioneuronal tumours.
    Dyke J; Calapre L; Beasley A; Gray E; Allcock R; Bentel J
    Pathol Res Pract; 2022 Jan; 229():153724. PubMed ID: 34942511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy-related protein expression was associated with BRAF V600E mutation in epilepsy associated glioneuronal tumors.
    Shen CH; Zhang YX; Xu JH; Zhu QB; Zhu JM; Guo Y; Ding Y; Wang S; Ding MP
    Epilepsy Res; 2017 Sep; 135():123-130. PubMed ID: 28667867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF V600E mutation in epilepsy-associated glioneuronal tumors: Prevalence and correlation with clinical features in a Chinese population.
    Zhang YX; Shen CH; Guo Y; Zheng Y; Zhu JM; Ding Y; Tang YL; Wang S; Ding MP
    Seizure; 2017 Feb; 45():102-106. PubMed ID: 27984807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA519d and microRNA4758 can identify gangliogliomas from dysembryoplastic neuroepithelial tumours and astrocytomas.
    Bongaarts A; Prabowo AS; Arena A; Anink JJ; Reinten RJ; Jansen FE; Spliet WGM; Thom M; Coras R; Blümcke I; Kotulska K; Jozwiak S; Grajkowska W; Söylemezoğlu F; Pimentel J; Schouten-van Meeteren AYN; Mills JD; Iyer AM; van Vliet EA; Mühlebner A; Aronica E
    Oncotarget; 2018 Jun; 9(46):28103-28115. PubMed ID: 29963264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse form of dysembryoplastic neuroepithelial tumour: the histological and immunohistochemical features of a distinct entity showing transition to dysembryoplastic neuroepithelial tumour and ganglioglioma.
    Bodi I; Selway R; Bannister P; Doey L; Mullatti N; Elwes R; Honavar M
    Neuropathol Appl Neurobiol; 2012 Aug; 38(5):411-25. PubMed ID: 21988102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioneuronal tumours with features of rosette-forming glioneuronal tumours of the fourth ventricle and dysembryoplastic neuroepithelial tumours: a report of three cases.
    Chen SY; Wang W; Wang LM; Lin QT; Zhao GG; Xu G; Lu DH; Piao YS
    Histopathology; 2016 Feb; 68(3):378-87. PubMed ID: 26040650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three gangliogliomas: results of GTG-banding, SKY, genome-wide high resolution SNP-array, gene expression and review of the literature.
    Xu LX; Holland H; Kirsten H; Ahnert P; Krupp W; Bauer M; Schober R; Mueller W; Fritzsch D; Meixensberger J; Koschny R
    Neuropathology; 2015 Apr; 35(2):148-57. PubMed ID: 25376146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
    Fina F; Barets D; Colin C; Bouvier C; Padovani L; Nanni-Metellus I; Ouafik L; Scavarda D; Korshunov A; Jones DT; Figarella-Branger D
    Oncotarget; 2017 Jan; 8(2):2104-2113. PubMed ID: 27791984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases.
    Pagès M; Debily MA; Fina F; Jones DTW; Saffroy R; Castel D; Blauwblomme T; Métais A; Bourgeois M; Lechapt-Zalcman E; Tauziède-Espariat A; Andreiuolo F; Chrétien F; Grill J; Boddaert N; Figarella-Branger D; Beroukhim R; Varlet P
    Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12834. PubMed ID: 35836307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours.
    Stone TJ; Keeley A; Virasami A; Harkness W; Tisdall M; Izquierdo Delgado E; Gutteridge A; Brooks T; Kristiansen M; Chalker J; Wilkhu L; Mifsud W; Apps J; Thom M; Hubank M; Forshew T; Cross JH; Hargrave D; Ham J; Jacques TS
    Acta Neuropathol; 2018 Jan; 135(1):115-129. PubMed ID: 29058119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour types.
    Reinhardt A; Pfister K; Schrimpf D; Stichel D; Sahm F; Reuss DE; Capper D; Wefers AK; Ebrahimi A; Sill M; Felsberg J; Reifenberger G; Becker A; Prinz M; Staszewski O; Hartmann C; Schittenhelm J; Gramatzki D; Weller M; Olar A; Rushing EJ; Bergmann M; Farrell MA; Blümcke I; Coras R; Beckervordersandforth J; Kim SH; Rogerio F; Dimova PS; Niehusmann P; Unterberg A; Platten M; Pfister SM; Wick W; Herold-Mende C; von Deimling A
    Neuropathol Appl Neurobiol; 2022 Dec; 48(7):e12847. PubMed ID: 35977725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioneuronal tumours in neurofibromatosis type 1: MRI-pathological study.
    Fedi M; Anne Mitchell L; Kalnins RM; Gutmann DH; Perry A; Newton M; Brodtmann A; Berkovic SF
    J Clin Neurosci; 2004 Sep; 11(7):745-7. PubMed ID: 15337138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation-based classification of glioneuronal tumours synergises with histology and radiology to refine accurate molecular stratification.
    Stone TJ; Mankad K; Tan AP; Jan W; Pickles JC; Gogou M; Chalker J; Slodkowska I; Pang E; Kristiansen M; Madhan GK; Forrest L; Hughes D; Koutroumanidou E; Mistry T; Ogunbiyi O; Ahmed SW; Cross JH; Hubank M; Hargrave D; Jacques TS
    Neuropathol Appl Neurobiol; 2023 Apr; 49(2):e12894. PubMed ID: 36843390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: the implication of a common progenitor cell?
    Matsumura N; Yokoo H; Mao Y; Yin W; Nakazato Y
    Neuropathology; 2013 Jun; 33(3):246-55. PubMed ID: 23025580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pi3K-mTOR signaling and AMOG expression in epilepsy-associated glioneuronal tumors.
    Boer K; Troost D; Timmermans W; van Rijen PC; Spliet WG; Aronica E
    Brain Pathol; 2010 Jan; 20(1):234-44. PubMed ID: 19371356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive characterization of genomic aberrations in gangliogliomas by CGH, array-based CGH and interphase FISH.
    Hoischen A; Ehrler M; Fassunke J; Simon M; Baudis M; Landwehr C; Radlwimmer B; Lichter P; Schramm J; Becker AJ; Weber RG
    Brain Pathol; 2008 Jul; 18(3):326-37. PubMed ID: 18371186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD34 as a novel marker for glioneuronal lesions associated with chronic intractable epilepsy.
    Deb P; Sharma MC; Tripathi M; Sarat Chandra P; Gupta A; Sarkar C
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):461-8. PubMed ID: 16972880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide DNA copy number analysis of desmoplastic infantile astrocytomas and desmoplastic infantile gangliogliomas.
    Gessi M; Zur Mühlen A; Hammes J; Waha A; Denkhaus D; Pietsch T
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):807-15. PubMed ID: 23965740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumours arising in the setting of paediatric chronic epilepsy.
    Prayson RA
    Pathology; 2010; 42(5):426-31. PubMed ID: 20632818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.